+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharming Group NV - logo

The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Hereditary Angioedema Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 185 Pages
  • Global
From
Hereditary Angioedema (HAE) Therapeutics Market 2024-2028 - Product Thumbnail Image

Hereditary Angioedema (HAE) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 161 Pages
  • Global
From
Angioedema Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Angioedema Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
Hereditary Angioedema Therapeutics Market Size, Share & Trends Analysis Report By Treatment (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Market Size, Share & Trends Analysis Report By Treatment (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 100 Pages
  • Global
From
Angioedema- Pipeline Insight, 2025 - Product Thumbnail Image

Angioedema- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 79 Pages
  • Global
From
Glucosylceramidase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Glucosylceramidase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • September 2024
  • 95 Pages
  • Global
From
United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

United States Hereditary Angioedema Therapeutics Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 160 Pages
  • United States
From
Fibrin Sealants Market 2024-2028 - Product Thumbnail Image

Fibrin Sealants Market 2024-2028

  • Report
  • June 2024
  • 146 Pages
  • Global
From
Plasma Protease C1-inhibitor Treatment - Global Strategic Business Report - Product Thumbnail Image

Plasma Protease C1-inhibitor Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Plasma Protease C1 Inhibitor Market 2024-2028 - Product Thumbnail Image

Plasma Protease C1 Inhibitor Market 2024-2028

  • Report
  • January 2024
  • 166 Pages
  • Global
From
Kallikrein Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

Kallikrein Inhibitors Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Immunologic Deficiency Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Immunologic Deficiency Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fibrin Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Fibrin Sealant Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 100 Pages
  • Global
From
Fibrin Glue Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Fibrin Glue Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 91 Pages
  • Global
From
Complement C1s Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1s Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Plasma Protease C1-inhibitor Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Plasma Protease C1-inhibitor Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 78 Pages
  • Global
From
Alpha Galactosidase A Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Alpha Galactosidase A Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 105 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 1000 Pages
  • Global
From
Rare Autoinflammatory Diseases Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Rare Autoinflammatory Diseases Drug Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Loading Indicator